Connecting you to content on EBSCOhost

Works matching IS 17534658 AND DT 2011 AND VI 5 AND IP 5

Results: 5

1

Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 345, doi. 10.1177/1753465811410100

By:

Vogelmeier, Claus;
Magnussen, Helgo;
LaForce, Craig;
Owen, Roger;
Kramer, Benjamin

Publication type:

Article

2

The role of sphingolipids in respiratory disease.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 325, doi. 10.1177/1753465811406772

By:

Yang, Yang;
Uhlig, Stefan

Publication type:

Article

3

Is the patient’s baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 289, doi. 10.1177/1753465811407236

By:

Aubier, Michel;
Haughney, John;
Selroos, Olof;
van Schayck, Onno C. P.;
Ekström, Tommy;
Ostinelli, Juliette;
Buhl, Roland

Publication type:

Article

4

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 299, doi. 10.1177/1753465811407786

By:

Haroon, Muhammad;
McLaughlin, Patrick;
Henry, Michael;
Harney, Sinead

Publication type:

Article

5

Management of fungal lung disease in the immunocompromised.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 305, doi. 10.1177/1753465811398720

By:

Islam, Anowara;
Mody, Christopher H.

Publication type:

Article